drugset / Trial / NCT02215356
Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomised, multi-center, controlled trial is designed to assess the efficacy and safety of icotinib with concurrent radiotherapy versus chemotherapy with concurrent radiotherapy in non-small cell lung cancer
Timeline
- Start
- 2014-08
- Primary completion
- 2018-08
- Completion
- 2019-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cisplatin | Other / unclassified | 50 mg/m2 | Intravenous |
| Comparator | Etoposide | Small molecule | 50 mg/m2 | Intravenous |
| Subject | Icotinib | Small molecule | 125 mg | Oral |